Cripto Is a Noncompetitive Activin Antagonist That Forms Analogous Signaling Complexes with Activin and Nodal
Jonathan A. Kelber(University of California, San Diego), Peter C. Gray(Salk Institute for Biological Studies)
Cited by 67
Related Papers
Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance
|bioRxiv (Cold Spring Harbor Laboratory)|2023|4
Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic progression and decreased patient survival
|Biochemical and Biophysical Research Communications|2024|2